Skip to content

Concerto NV-4-8-Helix

by Micro Therapeutics, Inc.

Concerto NV-4-8-Helix is a Class II device made by Micro Therapeutics, Inc., cleared under FDA 510(k) K090046 on 27 Feb 2009 and listed in FDA GUDID since 16 Oct 2015 (UDI-DI 00836462013032), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K090046

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00836462013032 UDI-DI Date16 Oct 2015ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Special NumberK090046 Date27 Feb 2009DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K090046 decided 27 Feb 2009 Active
  • FDA GUDID UDI-DI 00836462013032 listed 16 Oct 2015 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K090046
  2. Listed FDA GUDID 00836462013032

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Concerto
Generic name
Neurovascular embolization coil
Model / Ref / Catalog
NV-4-8-HELIX
Primary DI / UDI-DI
00836462013032
510(k) Number
FDA product code
KRD
GMDN term
Neurovascular embolization coil
Device class
Class II
Regulation number
870.3300
GUDID distribution status
In Commercial Distribution
MRI safety
MR Conditional
Size
Length — 8 Centimeter
Outer Diameter — 4 Millimeter

Other devices from Micro Therapeutics, Inc.

See all devices from Micro Therapeutics, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)